[Adeno-associated virus-mediated expression of human endostatin and its biological activity in vitro].
OBJECTIVE
To construct the recombinant adeno-associated viral vector containing human endostatin gene (rAAV-hEndo) and observe the biological activity of the expressed human endostatin in vitro.


METHODS
rAAV-hEndo was prepared using a helper virus-free packaging system. The rAAV viral genome titer was quantified by Taqman real-time PCR, and the endostatin expressed in human umbilical vein endothelial cell line ECV304 was detected by immunofluorescence staining. The effects of endostatin on ECV340 cells were evaluated by MTT cell proliferation assay, cell cycle analysis and terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling (TUNEL) technique.


RESULTS
The viral titer of rAAV-hEndo prepared was 2 x 10(12) vg/ml and the vector had an infection efficiency of 98%. Immunofluorescence staining showed that the human endostatin protein was expressed mainly in the cytoplasm of ECV304 cells, and the proliferation of the cells was obviously inhibited by the supernatant of rAAV-hEndo, with a inhibition rate of 67.3% 72 h after the addition of the supernatant. ECV304 cells infected with rAAV-hEndo were obviously arrested in G(1) phase, and the G(1)-phase cell percentage of treatment group were significantly higher than that of control group [(72.5+/-4.0)% vs (52.1+/-2.1)%, P<0.01]. ECV304 cells infected with rAAV-hEndo demonstrated markedly enhanced apoptosis, with a significantly greater apoptotic index than that of the control cells [(32.6+/-3.2)% vs (4.2+/-1.9)%, P<0.01].


CONCLUSIONS
rAAV-hEndo can effectively mediate the expression of biologically active human endostatin, which may facilitate further study of antiangiogenic gene therapy with endostatin for cancers.
Li
Xiao-hua
XH
Department of Otolaryngology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Li
Xiang-ping
XP
Li
Gang
G
Liu
Xiong
X
D049109:Cell Proliferation; D002478:Cells, Cultured; D000229:Dependovirus / Q000235:genetics / Q000378:metabolism*; D043169:Endostatins / Q000096:biosynthesis* / Q000235:genetics; D004730:Endothelium, Vascular / Q000166:cytology / Q000378:metabolism*; D005822:Genetic Vectors; D006801:Humans; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000235:genetics; D011995:Recombination, Genetic; D014162:Transfection; D014471:Umbilical Veins / Q000166:cytology
D043169:Endostatins; D011994:Recombinant Proteins